Daniel Garcia, MD, PhD

Senior Director, Global Medical Affairs, Clinical Development

Poster(s):

• (P109) ATRIAL FIBRILLATION INDUCIBILITY AFTER PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA ABLATION
  Thursday, October 24, 2024

  12:00 PM – 12:30 PM PT

• (P235) COMPASSIONATE USE OF EVINACUMAB FOR THE TREATMENT OF HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLAEMIA (HOFH) IN CHILDREN UNDER 5 YEARS OF AGE: CLINICAL EXPERIENCE
  Thursday, October 24, 2024

  1:30 PM – 2:00 PM PT